{"transactions":[{"id":2600648,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":27987,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27987,"derivative":{"exercise_price":20.5,"exercise_date":"2016-11-15","expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":27987},"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600647,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1a Warrants","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":573750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO."}],"balance_after":0,"derivative":{"exercise_date":"2016-11-15","expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":27987},"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600646,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1 Preferred Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":1755622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":85640},"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600645,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1c Preferred Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":25582050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1247904},"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600644,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1b Preferred Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":3722500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":181585},"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600643,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1a Preferred Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":2295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":111951},"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600642,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1d Preferred Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":2436657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":361147},"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600641,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":85640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":2905544,"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600640,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":1247904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":2819904,"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600639,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":181585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":1572000,"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600638,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":111951,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":1390415,"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600637,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136229,"kind":"organization","name":"Proehl Investment Ventures LLC","position":1,"cik":"0001877913","reported_name":"Proehl Investment Ventures LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T12:48:25.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":361147,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":1278464,"source":{"system":"sec-edgar","filing":"0000905718-21-001108","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877913/000090571821001108/dermata_fm4aug172021.xml","form_type":"4"}}]}